Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104263802B enables high-purity S-1-tetrahydronaphthalene amines via dynamic kinetic resolution, ensuring supply chain reliability.
Patent CN101977891B reveals high yield carbamate process reducing heavy metal use. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Advanced process for CNS drug intermediates via optimized Pd-coupling. Enhances yield and scalability for cost reduction in API manufacturing.
Patent CN108484412A details transparent polyimide precursors. Offers supply chain stability and cost efficiency for electronic chemical manufacturing processes globally.
Patent CN105503613B reveals advanced Cu Ni catalyst for polyamine production offering reduced corrosion and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN1538950A details a mild transfer hydrogenation method for amine synthesis using Ru/Rh catalysts, offering cost reduction in API manufacturing and high optical purity.
Novel hydroformylation method for 3,3-diarylpropylamines. Efficient Rh-catalyzed route for API intermediates like Tolterodine. Cost-effective scale-up.
Patent CN1516689A details a novel route for fexofenadine via regioselective acylation and crystallization, offering cost reduction in pharmaceutical manufacturing.
Patent CN102076634A details enantioselective hydrogenation of N-H imines. Discover cost-effective routes for high-purity pharmaceutical intermediates without protection steps.
Patent CN1296472A reveals a method suppressing by-products for high-yield diamine synthesis, offering cost-effective supply chain solutions.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN103965057A reveals a copper-catalyzed reduction method offering high purity and safety. Ideal for cost reduction in fine chemical manufacturing and supply chain reliability.
Explore the patented Grignard-based synthesis of Doxylamine Succinate (CAS 562-10-7). A scalable, high-purity route for pharmaceutical manufacturing and cost reduction.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN1121706A reveals a non-halide route for substituted aromatic amines, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN111995525A reveals a mild hydrogenation method using nanoporous PtFe catalyst, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110627703B reveals a room-temperature difluoromethylation method. This breakthrough offers significant cost reduction in API manufacturing and ensures high-purity intermediates.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.